01 1Life Science Logistics LLC
02 1Qingdao Biopeptek Co., Ltd.
01 2Inositol
01 1U.S.A
02 1Blank
NDC Package Code : 73212-094
Start Marketing Date : 2024-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42067-180
Start Marketing Date : 2024-01-08
End Marketing Date : 2026-09-24
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Inositol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Inositol, including repackagers and relabelers. The FDA regulates Inositol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Inositol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Inositol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Inositol supplier is an individual or a company that provides Inositol active pharmaceutical ingredient (API) or Inositol finished formulations upon request. The Inositol suppliers may include Inositol API manufacturers, exporters, distributors and traders.
click here to find a list of Inositol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Inositol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Inositol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Inositol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Inositol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Inositol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Inositol suppliers with NDC on PharmaCompass.
We have 1 companies offering Inositol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
